North America to Dominate the Global Hospital Acquired Infection Control Market till 2026
Increase in hospital stay duration and
prevalence of chronic diseases is expected to drive the demand for global hospital
acquired infection control market in the forecast period.
According to TechSci Research report, “Global
Hospital
Acquired Infection Control Market By Product (Sterilizers, Disinfectors,
Endoscope Reprocessors, Others) By Application (Disease Testing,
Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods)
By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site
Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals,
ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity
Centers, Others) By Company, By Region, Forecast & Opportunities, 2026”,
the global hospital acquired infection control market is expected to witness
steady growth for the next five years. Hospital acquired infection are
generally caused due to presence of pathogens who spread quickly in the human
body and affect the health system adversely. Infections are treated either by
following a proper diet and routine or by taking antibiotics and by encouraging
the natural healing process. Presence of unhygienic conditions inside and
outside of healthcare facilities in addition with adoption of improper
sterilization techniques in healthcare centers is aiding in increasing the
growth of the hospital acquired infection control market across the globe. Rising
disposable income among the consumers is boosting the expenditure capacity for
availing healthcare facilities. Economic development of developing economies
and presence of large population suffering with different diseases is
considered a major driver for the growth of the market in the forecast period.
High-end investments by the government to develop the healthcare facilities is
increasing the adoption rate of medical devices thereby fueling the market
growth for the predicted period. Surge in demand of medical devices which are
capable of disinfecting for example endoscope reprocessing device is
influencing the growth of the market. Technological evolutions enhancing the
safety of patients and can prevent cross contaminations among patients are
gaining high demand from healthcare industry. Virulence of microbial agents,
immunity power of patients and environmental factors such as infected materials
are some other prominent factors fueling the market. Government initiatives to
prevent the infection and ensure high degree of infection prevention are
releasing the set of precautionary measures and guidelines and also promotion
for efficient disease prevention which is expected to accelerate the growth of
the hospital acquired infection control market.
However, off label use of antibiotic drugs along
with growth of microbial resistance which may create hindrance in the global hospital
acquired infection control market growth.
Browse XX Figures spread through XX Pages and an in-depth
TOC on "Global Hospital
Acquired Infection Control Market”.
https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html
Global hospital acquired infection control market is
segmented into product, application, technology, disease, end user, region, and
company. Based on product, market is further divided into sterilizers, disinfectors,
endoscope reprocessors and others. Disinfector segment is expected to account
for major market share for the forecast period, 2022-2026. Disinfectors are
further classified into hand disinfectants, skin disinfectants, instrument
disinfectants, and surface disinfectants/ disinfectant robots. High demand from
consumers for different applications is aiding to huge market share over the
predicted period. Disinfection is a process of removal of all pathogenic
microorganisms which is achieved by use of liquid chemicals or by the process
of wet pasteurization. Based on end user, market is categorized into hospitals,
ICUs, ambulatory surgical, diagnostic centers, nursing homes, maternity centers
among others. Hospitals followed closely by ICUs segment is expected to
dominate the hospital acquired infection control market. Based on technology,
hospital segment is bifurcated into phenotypic methods and genotypic methods. Phenotypic
methods are further classified into colorimetric methods, nitrate reductase
assay and phage-based assays. Genotypic methods are sub-segmented into solid-phase
hybridization techniques, DNA sequencing, polymerase chain reaction (PCR)
techniques and microarrays.
Becton, Dickinson and Company, Steris Corporation Ltd.,
Advanced Sterilization Products, Getinge Group, Kimberly-Clark Corporation,
Cantel Medical Corporation, BioMérieux SA, Belimed AG, 3M company, Sterigenics
International LLC, Synergy Health PLC, Olympus Corporation Ltd, Danaher
Corporation Ltd. (Cepheid), Crosstex International, Inc., Diversey Inc are the
leading players operating in global hospital acquired infection control market.
Manufacturers are increasingly focusing on research and development process to
fuel higher growth in the market. To meet evolving customer demand with respect
to better efficiency and durability, several hospitals acquired infection
control equipment manufacturers are coming up with their technologically
advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7617
Customers
can also request for 10% free customization on this report.
“Prevailing
condition of pandemic which requires strict control over hospital acquired
control along with high-end investments by major market players for development
of technology such as gas plasma sterilization process for expansion of
hospital acquired infection control market is aiding to increase market growth.
High prevalence of HAI and poor training and infection control practices, poor
healthcare infrastructure and lack of awareness are some of the other prominent
factors which are anticipated to propel the market growth until 2026” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Global Hospital Acquired Infection Control Market By Product
(Sterilizers, Disinfectors, Endoscope Reprocessors, Others) By Application
(Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods,
Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream
Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others)
By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing
Homes, Maternity Centers, Others) By Company, By Region, Forecast &
Opportunities, 2026” has evaluated the
future growth potential of global hospital acquired infection control market
and provided statistics & information on market size, shares, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the of global hospital
acquired infection control market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/